[1]
Thewjitcharoen, Y. et al. 2022. CLINICAL EFFECTIVENESS OF ONCE-WEEKLY DULAGLUTIDE AS ADD-ON TO SGLT2i IN THAI PATIENTS WITH T2DM: RETROSPECTIVE STUDY IN A REAL- WORLD SETTING. Journal of the ASEAN Federation of Endocrine Societies. 37, 2 (Oct. 2022), 37–38. DOI:https://doi.org/10.15605/jafes.037.AFES.53.